Publications by authors named "Mark Kieh"

Claim this Profile
E
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial.
Simon Valayer, Marie Alexandre, Mélanie Prague, Abdoul Habib Beavogui, Seydou Doumbia, Mark Kieh

Emerg Microbes Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.
Elissa Malkin, Marija Zaric, Mark Kieh, Lindsey R Baden, David Fitz-Patrick

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vector-Induced Humoral Responses After rVSVΔG-ZEBOV-GP Immunization Identify Vaccinated Individuals and Correlate With Ebola Virus Glycoprotein Antibodies.
Prabha Chandrasekaran, Irina Maljkovic Berry, Viviane Callier, Scott M Anthony, Krystle Hensley, Mark Kieh

J Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Andrew W Lee, Ken Liu, Edouard Lhomme, Julie Blie, John McCullough, Mark Kieh

Clin Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey.
Stephen B Kennedy, Grace R Macklin, Gloria Mason Ross, Rocio Lopez Cavestany, Richelot A Moukom, Mark W S Kieh

Lancet Glob Health· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory.
Chelsea McLean, Houreratou Barry, Mark Kieh, Zacchaeus Anywaine, Baimba Tapima Rogers

EBioMedicine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical research as a critical component of epidemic response: the case of PREVAIL in Liberia.
Mosoka P Fallah, H Clifford Lane, Elizabeth S Higgs, Stephen B Kennedy, Moses B F Massaquoi, Mark W S Kieh

Lancet Glob Health· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Vaccines for Zaire Ebola Virus Disease.

N Engl J Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Moses Badio, Edouard Lhomme, Mark Kieh, Abdoul Habib Beavogui, Stephen B Kennedy

Trials· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Moses Badio, Edouard Lhomme, Mark Kieh, Abdoul Habib Beavogui, Stephen B Kennedy

Trials· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult and paediatric haematology and clinical chemistry laboratory reference limits for Liberia.
Mark W Kieh, Sarah M Browne, Greg A Grandits, Julie Blie, Jestina W Doe-Anderson

Afr J Lab Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of Ebola virus disease through vaccination: where we are in 2018.
Yves Lévy, Clifford Lane, Peter Piot, Abdul Habib Beavogui, Mark Kieh

Lancet· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome.
Ian A Myles, Erik D Anderson, Noah J Earland, Kol A Zarember, Inka Sastalla, Mark D Kieh

J Clin Invest· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis.
Ian A Myles, Noah J Earland, Erik D Anderson, Ian N Moore, Mark D Kieh

JCI Insight· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.
Stephen B Kennedy, Fatorma Bolay, Mark Kieh, Greg Grandits, Moses Badio

N Engl J Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak.
Mark D Kieh, Elim M Cho, Ian A Myles

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 T cell dialyzable extract activity is dependent on TCR and MHC-I.
Mark D Kieh, Sandip K Datta, Ian A Myles

J Leukoc Biol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional Wisdom versus Actual Outcomes: Challenges in the Conduct of an Ebola Vaccine Trial in Liberia during the International Public Health Emergency.
Gregg S Larson, Beth R Baseler, Marie L Hoover, Jerome F Pierson, Jemee K Tegli, Mark W S Kieh

Am J Trop Med Hyg· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Ebola virus disease laboratory system and related challenges in Liberia.
Stephen B Kennedy, John B Dogba, Christine L Wasunna, Philip Sahr, Candace B Eastman, Mark W S Kieh

Afr J Lab Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The laboratory health system and its response to the Ebola virus disease outbreak in Liberia.
Stephen B Kennedy, Christine L Wasunna, John B Dogba, Philip Sahr, Candace B Eastman, Mark W S Kieh

Afr J Lab Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges.
Stephen B Kennedy, James D Neaton, H Clifford Lane, Mark W S Kieh, Moses B F Massaquoi

Clin Trials· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis